indium has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CT; Guan, SS; Liao, TZ; Lin, KL; Liu, SH; Peng, CL; Shih, YH; Wang, YC; Weng, MF; Wu, CT; Yeh, CH | 1 |
Bellaye, PS; Bernhard, C; Brunotte, F; Cochet, A; Collin, B; Denat, F; Dumont, L; Moreau, M; Oudot, A; Raguin, O; Vandroux, D; Vrigneaud, JM | 1 |
2 other study(ies) available for indium and Colorectal Neoplasms
Article | Year |
---|---|
A novel
Topics: Acetazolamide; Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Humans; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2021 |
Radiolabeled F(ab')
Topics: Animals; Cetuximab; Colorectal Neoplasms; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Radioimmunodetection; Radiopharmaceuticals; Skin Neoplasms; Theranostic Nanomedicine; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2018 |